HOME ABOUT MASCON PRODUCTS MARKETING NEWS FLASH CONTACT US FEEDBACK

Message from Managing Director.!

MASCON >> where quality matters...!

Product List
Floroflox (Drops)
Dexadron-T (Drops)
Tiloptic (Drops)
Minoside (Drops)
Lutevit Plus (Tablets)
Lutevit Plus (Syrup)
Samotec-50 (Tablets)
   
 
About Us      (A short about MASCON PHARMACAL)
MASCON PharmaCal  is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1990, MASCON discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs 

We discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. We also focus on getting the best from every medicine we make by exploring all the ways it can be used or improved.

At MASCON, innovation is about more than just research. We aim to stimulate continued creativity throughout our organization by maintaining a culture in which our people feel valued, energized and rewarded for their ideas and contribution to our success - ideas which can make a difference in all aspects of our business. And we support and encourage our people in discovering their own potential, through excellent learning and development opportunities that are available to them throughout their careers.

With a global business comes a global responsibility for consistently high standards of behavior worldwide. We aim to effectively manage that responsibility and help to find new ways of bringing benefit to society to ensure that MASCON continues to be welcomed as a valued member of the global community.

We are committed to continued achievement in all of these areas to ensure a healthy future for our business so that we can continue to help improve the lives of, and add value for, all those who benefit from it.